The one-year results from the Vascular Endothelial Growth Factor Trap-Eye for Macular Edema Secondary to Central Retinal Vein Occlusion (COPERNICUS) study [12] showed that aflibercept significantly improved macular edema and vision compared with observation. The gene discussed is VEGFA; the disease is macular retinal edema.